Skip to content

Health Related Quality of Life Effects of Off-the-shelf Computer Gaming in Alzheimer and Related Disorders Populations

Health Related Quality of Life Effects of Off-the-shelf Computer Gaming in Alzheimer and Related Disorders Populations

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01416012
Enrollment
31
Registered
2011-08-12
Start date
2011-10-31
Completion date
2014-01-31
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disease Alzheimer

Brief summary

Interactive games (virtual reality) have recently been the center of interest and scientific discussion in the field of cognitive and functional rehabilitation. From their entertaining and contextual aspects, off-the-shelf video games are potentially interesting tools as adjunct to the patient care, especially for maintaining instrumental activities of daily living (IADL) autonomy. Disease and physical inactivity worsen the patient's ability in the IADLs, thus reducing health related quality of life (HRQL). This decrease in cognitive and functional abilities can be slowed down using adapted rehabilitation program. However, there is no randomized controlled study comparing usual physical therapy to virtual reality gaming consoles such as the Nintendo Wii or the Xbox 360 Kinect. Off-the-shelf gaming consoles offer a large range of games where cognitive and functional abilities from geriatric patients could be stimulated and consequently HRQL improved. However, a better knowledge of the potential cognitive and functional improvement processes from virtual reality rehabilitation in institutional routine is needed to enhance the quality and the range of the available care in old adults. This study will not only be a validation platform of virtual reality as stand alone rehabilitation process but also will assess the cost effectiveness of off-the-shelf gaming consoles in HRQL improvement of old adults. The investigators will compare the efficacy of two off-the-shelf gaming consoles in HRQL changes of patients with Alzheimer disease and related disorders. •Method This study is a randomized controlled trial that comprises two study phases : Phase one; comparing three parallel groups where therapists and assessors will be kept blind of study objectives, and Phase two, the investigators will take the most cost-effective gaming console from phase one (Nintendo Wii or Xbox 360 Kinect) and the investigators will use it as an adjunct to physical therapy compared to physical therapy alone, with respect to the same amount of rehabilitation time. The interventions are of 120min/week for 6 weeks and a follow-up at 4 weeks after intervention. Patients will be randomized in either Xbox 360 Kinect group - a Nintendo Wii group - or physical therapy as the 'gold' standard condition. All groups will receive the same amount of rehabilitation time. Power and sample calculation for phase two will be based on phase one results.

Interventions

BEHAVIORALPhysical Therapy (standard)

This group consists of the usual physical therapy rehabilitation with a special emphasis on lower and upper limb and balance reinforcement.

BEHAVIORALBalance and Gait training in Individualized sessions

The NW group consists of the use of Nintendo Wii games that targeted upper and lower limbs as well as balance reinforcement.

BEHAVIORALKinect

The NW group consists of the use of Nintendo Wii games that targeted upper and lower limbs as well as balance reinforcement

BEHAVIORALGroup Xbox Kinect

The NW group consists of the use of Nintendo Wii games that targeted upper and lower limbs as well as balance reinforcement

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Able to understand complex instruction * Patients with Mild Cognitive Impairment, Alzheimer, Vascular or Alzheimer with cerebro-vascular components dementia. Geriatric patients with a cognitive level as described by the MMSE between 16 and 26. * Aged 60 and older * Signed informed consent (patient or career) Inclusion criteria for investigator center * Having a recruitment line from Memory center, outpatient clinic, daycare, nursing homes and long term care * Able to include 60 patients or more * Have the French main investigator protocol reviewed and validated by their local ethical committee.

Exclusion criteria

* Other type of dementia, psychiatric patients or patients with deemed behavioural disturbances * Patients using wheelchair for mobility * Patient with severe deficit in alertness, vision or motor functioning. * Bedridden patients

Design outcomes

Primary

MeasureTime frameDescription
questionnaires on quality of life16 weeks for each test* EQ-6D * BERG test * Timed Up and Go Test and dual task TUG test * Engagement using the Observational Assessment of Engagement (OME)

Secondary

MeasureTime frameDescription
tests on health16 weeks for each test* Trail making Test A and B * Visual Association Test * Mini Mental State Examination * Neuropsychiatric Inventory * Apathy Inventory * Strength of lower and upper limbs using dynamometer. * Rapid stepping test * 10 meters walk test

Countries

Australia, France, Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026